Medical Cytotoxicity News
-
CD Formulation Provides In Vitro Cytotoxicity Testing for Microspheres and Microneedles
In recent years, the field of drug delivery has witnessed great advancements in the development of microspheres and microneedles, revolutionizing the way drugs are administered. These innovative technologies offer targeted and sustained release of therapeutic agents, promoting improved patient compliance and efficacy. However, as with any medical product, it is crucial to assess the safety and ...
-
CD Formulation Empowers High-volume Manufacturing of Microspheres
Over the past decade, innovation in the field of microsphere production has reached new heights. Thanks to groundbreaking technology, CD Formulation has enabled mass production services for these versatile particles. Through a cutting-edge approach, CD Formulation is well-prepared to serve the industry by offering efficient and effective solutions for the mass fabrication of microspheres. From ...
-
CD Formulation Introduces Comprehensive Range of Microsphere and Microneedle Solutions for Pharma and Biotech Applications
CD Formulation, a leading provider of innovative pharmaceutical formulation services, has recently launched a comprehensive range of microsphere and microneedle solutions for pharmaceutical and biotech applications. The newly introduced solutions are focused on long-acting controlled-release microspheres and phase-transition microneedle patches, to meet the growing demand for novel ...
-
Creative Diagnostics Introduces CC50/IC50 Assay Services for Pharmaceutical Safety
As a consulting and experimental service provider specializing in virology and microbiology, Creative Diagnostics recently introduced CC50/IC50 Assay service with a high level of assay sensitivity and accuracy. The CC50 and IC50 will be plotted using a sigmoidal dose-response curve, and the selectivity index (SI) for each compound is estimated by dividing the CC50 with the IC50. Pharmaceutical ...
-
CIS Pharma contact lens care solution shows enhanced biocompatibility, unsurpassed concentration of hyaluronic acid and a powerful disinfection complex
CIS Pharma has successful up-scaled the production of its novel contact lens multipurpose and disinfection solution (MPDS) to an industrial setup. The contact lens care solution achieved excellent performance compared to products that are leading the markets. From an efficacy perspective, the antimicrobial performance against various bacteria & fungi was tested according to ISO 14729. The ...
-
FDA Grants ALung Emergency Use Authorization (EUA) to the ALung for the Treatment of COVID-19
PITTSBURGH – (BUSINESS WIRE) – April 24, 2020 – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced that the Food and Drug Administration (FDA) has granted the Company Emergency Use Authorization (EUA) designation to the Hemolung® Respiratory ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you